Patient-level costing analysis of paediatric short bowel syndrome care in a specialist tertiary centre
link.springer.com shows its articles on its own site.
Read the article on link.springer.com ↗Article · Apr 2022 · 1 min read
In brief
In brief
UK tertiary center study quantifies hospital costs for pediatric short bowel syndrome using patient-level costing data over 5 years. Median annual cost was £52,834 per patient, driven primarily by inpatient stays, pharmacy, and staffing, with costs declining substantially after the first 3 years following initial admission.
Written by the GCMD Library team from the article.
Abstract
Purpose
To undertake a pilot study estimating patient-level costs of care for paediatric short bowel syndrome (SBS) from the healthcare provider perspective.
Methods
A pilot group of patients with anatomical SBS was selected at a single specialist tertiary centre in the United Kingdom. The Patient Level Information and Costing System (PLICS) was used to extract costing data for all hospital-based activities related to SBS, from the implementation of PLICS in 2016 to April 2021. Patient-specific and pooled data were reported descriptively in per patient-year terms.
Results
Five patients had full PLICS data available for the 5-year study period and 2 patients had 4 years of data. The median cost for hospital care of SBS was £52,834 per patient-year (range £1804–£331,489). The key cost drivers were inpatient beds, pharmacy, and staffing costs, which made up > 60% of annual costs. In the first 3 years following index admission (n = 2), there was a steady decline in the annual cost of care to a level comparable with patients with established SBS.
Conclusion
Patient-level cost of care analysis for SBS is feasible using PLICS. Hospital-related costs vary widely between and within individual patients over time. Key drivers of cost are related to complications of SBS.